Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiomyopathy, Hypertrophic | 21 | 2024 | 1310 | 4.150 |
Why?
|
Benzylamines | 4 | 2024 | 247 | 0.980 |
Why?
|
Uracil | 4 | 2024 | 207 | 0.950 |
Why?
|
Ventricular Function, Left | 8 | 2024 | 3879 | 0.920 |
Why?
|
Ventricular Myosins | 1 | 2020 | 65 | 0.720 |
Why?
|
Stroke Volume | 6 | 2024 | 5496 | 0.680 |
Why?
|
Cardiomyopathies | 3 | 2021 | 1964 | 0.650 |
Why?
|
Fabry Disease | 1 | 2019 | 87 | 0.640 |
Why?
|
Echocardiography | 8 | 2024 | 4989 | 0.630 |
Why?
|
Aortic Valve Insufficiency | 1 | 2022 | 576 | 0.580 |
Why?
|
Mediastinal Cyst | 1 | 2017 | 29 | 0.560 |
Why?
|
Heart Septum | 3 | 2024 | 301 | 0.540 |
Why?
|
Diverticulum | 1 | 2017 | 137 | 0.510 |
Why?
|
Heart Ventricles | 3 | 2022 | 3807 | 0.430 |
Why?
|
Heart Neoplasms | 1 | 2017 | 362 | 0.430 |
Why?
|
Myocardial Contraction | 1 | 2017 | 1515 | 0.400 |
Why?
|
Pericardium | 1 | 2017 | 675 | 0.400 |
Why?
|
Exercise Tolerance | 1 | 2017 | 836 | 0.390 |
Why?
|
Ventricular Outflow Obstruction | 2 | 2023 | 261 | 0.350 |
Why?
|
Heart Valve Prosthesis | 1 | 2018 | 1462 | 0.340 |
Why?
|
Exercise Test | 1 | 2017 | 2127 | 0.330 |
Why?
|
Predictive Value of Tests | 6 | 2024 | 15266 | 0.320 |
Why?
|
Heart Atria | 1 | 2014 | 1345 | 0.300 |
Why?
|
Contrast Media | 1 | 2021 | 5307 | 0.300 |
Why?
|
Genetic Association Studies | 1 | 2017 | 2735 | 0.290 |
Why?
|
Aortic Valve Stenosis | 1 | 2018 | 2001 | 0.260 |
Why?
|
Sequoia | 1 | 2023 | 6 | 0.220 |
Why?
|
Death, Sudden, Cardiac | 2 | 2024 | 1555 | 0.210 |
Why?
|
Ventricular Function, Right | 2 | 2024 | 617 | 0.200 |
Why?
|
Quality of Life | 2 | 2023 | 13367 | 0.200 |
Why?
|
Adipokines | 1 | 2024 | 310 | 0.190 |
Why?
|
Risk Assessment | 4 | 2024 | 23996 | 0.190 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2024 | 323 | 0.170 |
Why?
|
Cardiac Surgical Procedures | 1 | 2014 | 3627 | 0.160 |
Why?
|
Natriuretic Peptide, Brain | 3 | 2024 | 1723 | 0.160 |
Why?
|
Prognosis | 6 | 2024 | 29629 | 0.150 |
Why?
|
Technetium Tc 99m Pyrophosphate | 1 | 2017 | 45 | 0.150 |
Why?
|
Coronary Artery Disease | 1 | 2017 | 6403 | 0.150 |
Why?
|
Humans | 30 | 2024 | 761596 | 0.140 |
Why?
|
Gadolinium | 1 | 2021 | 960 | 0.130 |
Why?
|
Heart Failure | 4 | 2024 | 11671 | 0.130 |
Why?
|
Coronary Vessel Anomalies | 1 | 2019 | 307 | 0.130 |
Why?
|
Nonlinear Dynamics | 1 | 2017 | 492 | 0.120 |
Why?
|
Amyloid Neuropathies, Familial | 1 | 2017 | 151 | 0.120 |
Why?
|
Disopyramide | 2 | 2024 | 16 | 0.120 |
Why?
|
Ventricular Remodeling | 1 | 2022 | 1267 | 0.120 |
Why?
|
Echocardiography, Doppler | 1 | 2017 | 897 | 0.110 |
Why?
|
Treatment Outcome | 7 | 2024 | 64685 | 0.110 |
Why?
|
Cause of Death | 1 | 2024 | 3683 | 0.110 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12973 | 0.100 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2019 | 1050 | 0.100 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2017 | 1068 | 0.100 |
Why?
|
Middle Aged | 12 | 2024 | 220921 | 0.100 |
Why?
|
Recovery of Function | 2 | 2024 | 2979 | 0.100 |
Why?
|
Diastole | 1 | 2014 | 782 | 0.100 |
Why?
|
Peptide Fragments | 2 | 2024 | 5112 | 0.100 |
Why?
|
Male | 15 | 2024 | 360846 | 0.100 |
Why?
|
Sex Characteristics | 1 | 2022 | 2639 | 0.090 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3415 | 0.090 |
Why?
|
Fibrosis | 1 | 2018 | 2049 | 0.090 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2022 | 2118 | 0.090 |
Why?
|
Proteomics | 1 | 2024 | 3848 | 0.090 |
Why?
|
Female | 15 | 2024 | 392705 | 0.090 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2024 | 774 | 0.080 |
Why?
|
Heart Diseases | 1 | 2022 | 2781 | 0.080 |
Why?
|
Aortic Valve | 1 | 2018 | 1955 | 0.080 |
Why?
|
Myocardium | 1 | 2021 | 4725 | 0.080 |
Why?
|
Radiopharmaceuticals | 1 | 2017 | 2650 | 0.070 |
Why?
|
Prospective Studies | 4 | 2024 | 54423 | 0.070 |
Why?
|
Coronary Angiography | 1 | 2019 | 4471 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6484 | 0.070 |
Why?
|
Risk Factors | 5 | 2024 | 74213 | 0.070 |
Why?
|
Aged | 10 | 2024 | 169310 | 0.070 |
Why?
|
Atrial Fibrillation | 1 | 2024 | 5127 | 0.060 |
Why?
|
Heart Defects, Congenital | 1 | 2022 | 4671 | 0.060 |
Why?
|
Time Factors | 3 | 2024 | 39969 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12059 | 0.060 |
Why?
|
Electrocardiography | 1 | 2017 | 6377 | 0.060 |
Why?
|
Adult | 7 | 2024 | 221210 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12463 | 0.050 |
Why?
|
Genotype | 1 | 2017 | 12990 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2024 | 10766 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 2 | 2021 | 36426 | 0.050 |
Why?
|
Calcium Channel Blockers | 1 | 2024 | 694 | 0.050 |
Why?
|
Glycine | 1 | 2024 | 663 | 0.050 |
Why?
|
Standard of Care | 1 | 2024 | 551 | 0.050 |
Why?
|
Constriction, Pathologic | 1 | 2024 | 1096 | 0.040 |
Why?
|
Oligonucleotides | 1 | 2023 | 582 | 0.040 |
Why?
|
Withholding Treatment | 1 | 2024 | 617 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2024 | 12341 | 0.040 |
Why?
|
Blood Proteins | 1 | 2024 | 1173 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2017 | 80647 | 0.040 |
Why?
|
Phenotype | 1 | 2017 | 16592 | 0.040 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2024 | 1241 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2024 | 39106 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20568 | 0.040 |
Why?
|
Cross-Over Studies | 1 | 2023 | 2079 | 0.040 |
Why?
|
Decision Support Techniques | 1 | 2024 | 1998 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2024 | 2759 | 0.030 |
Why?
|
Pyrimidines | 1 | 2024 | 3028 | 0.020 |
Why?
|
Health Status | 1 | 2024 | 4077 | 0.020 |
Why?
|
Signal Transduction | 2 | 2024 | 23447 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2024 | 3233 | 0.020 |
Why?
|
Animals | 1 | 2020 | 168475 | 0.020 |
Why?
|
Patient Care Team | 1 | 2018 | 2521 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2023 | 22176 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2019 | 4062 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2018 | 3600 | 0.020 |
Why?
|
Cohort Studies | 1 | 2024 | 41495 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2017 | 20100 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2017 | 58984 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 88326 | 0.010 |
Why?
|
Concepts
(112)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_